Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Press Releases.
Press releases published on August 29, 2025
Design Studio UI/UX Completes 100+ Projects Worldwide as Focus on User-Centered Digital Solutions Grows
EIN Presswire
·
August 29, 2025
Design Studio UI/UX today announced the successful completion of 100+ projects for clients worldwide. This milestone reflects a major industry trend. NEW YORK, NY, UNITED STATES, August 29, 2025 /EINPresswire.com/ -- To stay ahead, companies are turning …
Redefining Smart Healthcare: HID Series Medical-Grade Panel PCs Driving the Future of Clinical Data Management
EIN Presswire
·
August 29, 2025
Redefining Smart Healthcare: HID Series Medical-Grade Panel PCs Driving the Future of Clinical Data Management TAIPEI, NEW TAIPEI, TAIWAN, August 29, 2025 /EINPresswire.com/ -- Avalue Technology Inc. (TPEx: 3479.TWO), a global leader in industrial …
Personal Care ingredient Market Global Rising Demand & Huge Scope Till 2031
EIN Presswire
·
August 29, 2025
Asia-Pacific forecasted to register the fastest CAGR of 6.5%, driven by urbanization and changing consumer habits. WILMINGTON, DE, UNITED STATES, August 29, 2025 /EINPresswire.com/ -- The global personal care ingredients market is experiencing steady …
GA Top Docs Has Reviewed & Approved Dr. Ike Nwaobi of Village Medical For 2025
EIN Presswire
·
August 29, 2025
Ike Nwaobi, M.D. has been reviewed and approved by GA Top Docs based on merit for 2025. ATLANTA, GA, UNITED STATES, August 29, 2025 /EINPresswire.com/ -- With over a decade of experience in family medicine and a deep commitment to patient-centered care, …
7 Physicians at Garden State Pain & Orthopedics Awarded As NJ Top Docs
EIN Presswire
·
August 29, 2025
NJ Top Docs has reviewed and approved seven physicians at Garden State Pain …
Reusable Blood Hemodialyzer Market Size $4.91B in 2024, Projected to Reach $7.94B by 2034
EIN Presswire
·
August 29, 2025
The global reusable blood hemodialyzer market size was approximately USD 4.91 billion in 2024 and is projected to reach around USD 7.94 billion by 2034 PUNE, MAHARASHTRA, INDIA, August 29, 2025 /EINPresswire.com/ -- Executive summary The global …
Pharmaceutical Stability And Storage Services Market Growth Drivers, and Future Projections (2024-2034) at an 8.5% CAGR
EIN Presswire
·
August 29, 2025
Pharmaceutical stability and storage services market was valued at approximately USD 3.53 billion in 2024 is expected to reach around USD 7.97 billion by 2034 PUNE, MAHARASHTRA, INDIA, August 29, 2025 /EINPresswire.com/ -- Market Overview The global …
Blood Banking Devices Market Size, Share, Trends, and Forecast to 2034 with a 10.80% CAGR
EIN Presswire
·
August 29, 2025
The global blood banking devices market size was worth around USD 3.26 billion in 2024 and is predicted to grow to around USD 9.08 billion by 2034 PUNE, MAHARASHTRA, INDIA, August 29, 2025 /EINPresswire.com/ -- Market Overview The global blood …
Stair Lifts Market to Reach USD 1.8 Billion by 2035, Expanding at 4.7% CAGR from USD 1.1 Billion in 2024 | TMR
EIN Presswire
·
August 29, 2025
Stair Lifts Market to hit US$ 1.8 Bn by 2035, growing at 4.7% CAGR, driven by aging population and increasing demand for home mobility solutions. WILMINGTON, DE, UNITED STATES, August 29, 2025 /EINPresswire.com/ -- The stair lifts market has witnessed …
Aura Aesthetics Expands with New Office in Temecula, Offering Comprehensive Skincare Services
EIN Presswire
·
August 29, 2025
Aura Aesthetics, a leader in luxury esthetician services, is thrilled to announce the opening of its new office in Temecula, California. TEMECULA, CA, UNITED STATES, August 29, 2025 /EINPresswire.com/ -- Your Skin's Best Friend: Aura Aesthetics Opens in …
Bicycle Toxin Conjugates Clinical Trials FDA Approval Proprietary Technology Cancer Drugs Report 2025
GlobeNewswire
·
August 29, 2025
Delhi, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Global Bicycle Toxin Conjugates Clinical Trials, Proprietary Platforms …
RNA Polymerase I POL 1 Clinical Trials Companies FDA Approval Development Trends Report 2025
GlobeNewswire
·
August 29, 2025
Delhi, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Global RNA Polymerase I Clinical Trials, Development Trends By Indications, Target Approaches …
Tetraspecific Antibodies Clinical Trials FDA Approval Development Technologies Platforms Market Opportunity Companies Report 2025
GlobeNewswire
·
August 29, 2025
Delhi, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Global Tetraspecific Antibodies Clinical Trials, Proprietary Technologies, Therapeutic Approaches …
Bispecific Antibody Drug Conjugates ADC Clinical Trials FDA Approval Companies Commercial Launch Report 2025
GlobeNewswire
·
August 29, 2025
Delhi, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Drug Conjugates Clinical Trials, Development Platforms, Competitive Landscape and Market Opportunity Insight 2025 Report Findings and Highlights: First Bispecific Antibody Drug Conjugate …
Controlled Release Drug Delivery Market Size FDA Approved Drugs Clinical Trials Companies Report 2030
GlobeNewswire
·
August 29, 2025
Delhi, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Global Controlled Release Drug Delivery Market, Drug Dosage, Price, Sales and Clinical Trials Insight 2030 Report Finding and Highlights: Research Methodology Followed Global and Regional Market Overview Global …
OSE Immunotherapeutics Reaffirms its Strategic Priorities and Publishes Shareholder Q&A to Restore Information Ahead of AGM
GlobeNewswire
·
August 29, 2025
OSE Immunotherapeutics Reaffirms its Strategic Priorities and Publishes Shareholder Q&A to Restore Information Ahead of AGM Nantes, August 29, 2025, 8:00 a.m. CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today published a comprehensive …
OSE Immunotherapeutics Réaffirme ses Priorités Stratégiques et Publie un Document Questions-Réponses Destiné aux Actionnaires pour Rétablir l’Information Avant l’Assemblée Générale
GlobeNewswire
·
August 29, 2025
OSE Immunotherapeutics Réaffirme ses Priorités Stratégiques et Publie un Document Questions-Réponses Destiné aux Actionnaires pour Rétablir l’Information Avant l’Assemblée Générale NANTES, France - 29 août 2025, 8h00 CET – OSE Immunotherapeutics SA (ISIN: …
Santhera schliesst Vereinbarung mit Ikris Pharma Network über den Vertrieb von AGAMREE® (Vamorolon) in Indien
GlobeNewswire
·
August 29, 2025
Pratteln, Schweiz, 29. August 2025 – Santhera Pharmaceuticals (SIX: SANN) gibt die Unterzeichnung einer exklusiven Vereinbarung mit Ikris Pharma Network (Ikris) über den Vertrieb von AGAMREE® (Vamorolon) in Indien zur Behandlung von Duchenne- …
Santhera Enters into Agreement with Ikris Pharma Network for the Distribution of AGAMREE® (Vamorolone) in India
GlobeNewswire
·
August 29, 2025
Pratteln, Switzerland, 29 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Ikris Pharma Network (Ikris) to manage the distribution of AGAMREE® (vamorolone) in India, for the treatment of Duchenne …
Banner Year for Mesoblast With First FDA Product Approval and Successful Commercial Launch of Ryoncil®
GlobeNewswire
·
August 29, 2025
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today provided financial results and an operational update for the period ended June 30, 2025. …